In the U.S., Vafseo® (vadadustat) is approved for the treatment of anemia due to CKD in adults who have been receiving dialysis for at least three months. Nephrologists in the U.S. began prescribing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback